10-Q: Bellevue Life Sciences Acquisition Corp. Reports First Quarter 2024 Results, Faces Going Concern Uncertainty

Bellevue Life Sciences Acquisition Corp. reported a net loss for the first quarter of 2024 and faces substantial doubt about its ability to continue as a going concern.

Summary

• Bellevue Life Sciences Acquisition Corp. reported a net loss of $60,430 for the three months ended March 31, 2024, compared to a net income of $110,305 for the same period in 2023.
• The company's general and administrative expenses increased to $450,781 in Q1 2024 from $278,102 in Q1 2023.
• Interest income from investments held in the Trust Account was $480,824 in Q1 2024, up from $417,728 in Q1 2023.
• The company's cash balance decreased significantly from $15,419 at the end of 2023 to $3,637 as of March 31, 2024.
• The company has a working capital deficit of $2,676,899 as of March 31, 2024.
• The company has extended the deadline to complete a business combination to November 14, 2024.
• The company has entered into a business combination agreement with OSR Holdings Co. Ltd.
• The company faces substantial doubt about its ability to continue as a going concern due to its limited working capital and the approaching deadline to complete a business combination.

Sentiment

Score: 3

Explanation: The document presents a concerning financial situation with a net loss, low cash balance, and a going concern warning. While there is a business combination agreement in place, the company faces significant challenges and risks, leading to a negative sentiment.

Positives

• Interest income from investments held in the Trust Account increased to $480,824 in Q1 2024.
• The company has secured a business combination agreement with OSR Holdings Co. Ltd.
• The deadline to complete a business combination has been extended to November 14, 2024.

Negatives

• The company reported a net loss of $60,430 for the first quarter of 2024.
• General and administrative expenses increased significantly to $450,781 in Q1 2024.
• The company's cash balance decreased substantially to $3,637 as of March 31, 2024.
• The company has a significant working capital deficit of $2,676,899.
• The company faces substantial doubt about its ability to continue as a going concern.

Risks

• The company's limited working capital and the approaching deadline to complete a business combination raise substantial doubt about its ability to continue as a going concern.
• The company may be deemed an investment company under the Investment Company Act of 1940, which could force liquidation.
• The company may be subject to a 1% excise tax on redemptions of shares, which could reduce available cash.
• The company is not in compliance with Nasdaq listing rules regarding the minimum number of public holders and audit committee composition.
• The company's ability to complete a business combination is subject to various conditions, including a minimum cash requirement.

Future Outlook

The company is focused on completing its business combination with OSR Holdings Co. Ltd. by November 14, 2024, but faces significant challenges related to its financial condition and compliance with Nasdaq listing rules. The company's ability to continue as a going concern is uncertain.

Management Comments

• Management believes that the Company will not have sufficient working capital to meet its working capital needs through the earlier of the consummation of an Initial Business Combination or 21 months from the Initial Public Offering.
• Management intends to complete a business combination.

Industry Context

The report highlights the challenges faced by special purpose acquisition companies (SPACs), including the need to complete a business combination within a specified timeframe, the risk of being deemed an investment company, and the potential impact of excise taxes on redemptions. The company's struggles with liquidity and compliance are not uncommon in the SPAC landscape.

Comparison to Industry Standards

• The company's financial performance is weak compared to other SPACs that have successfully completed business combinations.
• The company's high operating expenses and low cash balance are concerning compared to industry benchmarks.
• The company's failure to maintain compliance with Nasdaq listing rules is a significant issue compared to other listed SPACs.
• The company's reliance on related-party loans for working capital is not uncommon for SPACs, but the level of dependence is high.
• The company's going concern warning is a significant negative compared to other SPACs that have a clear path to completing a business combination.

Related Party Transactions

• The Sponsor has advanced funds to the Company for the payment of expenses incurred in connection with the Initial Public Offering.
• The Sponsor has purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit.
• The company has issued unsecured promissory notes to the Sponsor and related parties.
• The company has an administrative support agreement with an affiliate of the Sponsor.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company is unable to complete a business combination and is forced to liquidate.
• The company's employees may face uncertainty about their future employment if the company is unable to continue as a going concern.
• The company's creditors may face the risk of not being repaid if the company is forced to liquidate.
• The company's potential business combination partner, OSR Holdings Co. Ltd., faces uncertainty about the future of the transaction.

Next Steps

• The company needs to complete its business combination with OSR Holdings Co. Ltd. by November 14, 2024.
• The company needs to regain compliance with Nasdaq listing rules regarding the minimum number of public holders and audit committee composition.
• The company needs to address its working capital deficit and ensure sufficient funding for operations.
• The company needs to monitor and address the potential impact of the 1% excise tax on redemptions.

Key Dates

Keywords

SPAC, Business Combination, Merger, Acquisition, Going Concern, Liquidation, Redemption, Trust Account, OSR Holdings, Nasdaq, Excise Tax